NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Leisurewear firm reports 13.5% decline in profits in six months to 2 August, with sales drop worst in North AmericaRead More
NBA Panic Meter Power Rankings: Which teams should be most concerned about the first roundApril 27, 2026